Explore Our Publications
At Magnolia Innovation, we are constantly striving to contribute meaningful data and analysis to the larger healthcare conversation.
Below are some of the independent and collaborative publications we have worked on recently.
Optimizing Clinical Trial Recruitment for Diversity and Inclusion
The Magnolia team was able to identify clinical trial recruitment strategies for Black and Hispanic patients through the pairing of our in-house claims database with custom primary market research.
![mag mag 9016 nb healthequitycasestudy lvf pdf](https://www.magnoliainnovation.com/wp-content/uploads/MAG-MAG-9016_NB_HealthEquityCaseStudy_LvF-pdf-1.jpg.webp)
Optimizing Clinical Trial Recruitment for Diversity and Inclusion
Recent findings suggest that Black and Hispanic patients were underdiagnosed and suboptimally treated for this condition and may experience a higher prevalence of this rare condition than previously reported.
![mag mag 9016 nb healthequitycasestudy lvf pdf](https://www.magnoliainnovation.com/wp-content/uploads/MAG-MAG-9016_NB_HealthEquityCaseStudy_LvF-pdf-1.jpg.webp)
Patient- and Caregiver-Reported Quality of Life and Burden of Disease in Wiskott-Aldrich Syndrome: Findings from a Multinational Survey
This multinational study aims to quantify both the caregiver and patient-related burdens of WAS and add to the existing literature by examining various domains of health-related QoL including symptom burden, transplant burden, time investment, social and emotional well-being, and professional status
![](https://www.magnoliainnovation.com/wp-content/uploads/ISPOR-Europe-2023-Poster_WAS-Disease-Burden_19Nov2023_vF-copy.webp)
Patient- and Caregiver-Reported Quality of Life and Burden of Disease in Wiskott-Aldrich Syndrome: Findings from a Multinational Survey
This multinational study aims to quantify both the caregiver and patient-related burdens of WAS and add to the existing literature by examining various domains of health-related QoL including symptom burden, transplant burden, time investment, social and emotional well-being, and professional status
![](https://www.magnoliainnovation.com/wp-content/uploads/ISPOR-Europe-2023-Poster_WAS-Disease-Burden_19Nov2023_vF-copy.webp)
The Broadsword and the Scalpel: Perspectives on Market Research in the Age of ChatGPT
What role can ChatGPT and its competitors play in market research?
![broadsword and scalpel cover](https://www.magnoliainnovation.com/wp-content/uploads/VA-MAG-9220_IBO_Magnolia-ChatGPT-Article.jpg.webp)
BMT InfoNet Partners With Market Research Firm Magnolia Innovation to Better Understand Their Community’s Needs
Magnolia Innovation volunteers its market research expertise to uncover user experience issues to support BMT InfoNet website
![](https://www.magnoliainnovation.com/wp-content/uploads/VA-MAG-9220_IBO_PatientAdvocacyGroupMarketResearchArticle_LV5-1-pdf.jpg-1.webp)
BMT InfoNet Partners With Market Research Firm Magnolia Innovation to Better Understand Their Community’s Needs
Magnolia Innovation volunteers its market research expertise to uncover user experience issues to support BMT InfoNet website
![](https://www.magnoliainnovation.com/wp-content/uploads/VA-MAG-9220_IBO_PatientAdvocacyGroupMarketResearchArticle_LV5-1-pdf.jpg-1.webp)
Academic Execs Share How Pharma Should Engage With Oncology Customers
Academic Institution Executives Weigh In on the Importance of Knowing the Business Side of Oncology and the Impact of the Cross-Functional Teams That Exist within Pharma
![](https://www.magnoliainnovation.com/wp-content/uploads/Webinar-Invite-FINAL.png.webp)
Academic Execs Share How Pharma Should Engage With Oncology Customers
Academic Institution Executives Weigh In on the Importance of Knowing the Business Side of Oncology and the Impact of the Cross-Functional Teams That Exist within Pharma
![](https://www.magnoliainnovation.com/wp-content/uploads/Webinar-Invite-FINAL.png.webp)
Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers
The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers
![](https://www.magnoliainnovation.com/wp-content/uploads/LCFAOD_Final-1-pdf-791x1024.jpg.webp)
Understanding the Impact of Long-chain Fatty Acid Oxidation Disorders for Patients and Caregivers
The Substantial Impact on Quality of Life for Individuals with LC-FAOD and Their Caregivers
![](https://www.magnoliainnovation.com/wp-content/uploads/LCFAOD_Final-2-pdf-791x1024.jpg.webp)
Understanding Caregiver Descriptions of Initial Signs and Symptoms to Improve Diagnosis to Metachromatic Leukodystrophy
How Recognizing early signs can lead to earlier diagnosis and intervention in MLD patients
![](https://www.magnoliainnovation.com/wp-content/uploads/Orphanet-2-2-pdf-791x1024.jpg.webp)
Understanding Caregiver Descriptions of Initial Signs and Symptoms to Improve Diagnosis to Metachromatic Leukodystrophy
How Recognizing early signs can lead to earlier diagnosis and intervention in MLD patients
![](https://www.magnoliainnovation.com/wp-content/uploads/Orphanet-2-3-pdf-791x1024.jpg.webp)
An International Study of Caregiver – Reported Burden and Quality of Life in Metachromatic Leukodystrophy
How MLD Caregivers Lives are Negatively Affected By the Burden of care
![](https://www.magnoliainnovation.com/wp-content/uploads/Orphanet-1-1-pdf-791x1024.jpg.webp)
An International Study of Caregiver – Reported Burden and Quality of Life in Metachromatic Leukodystrophy
How MLD Caregivers Lives are Negatively Affected By the Burden of care
![](https://www.magnoliainnovation.com/wp-content/uploads/Orphanet-1-2-pdf-791x1024.jpg.webp)
C-Suite Insights: Are Oncology Pharma Teams Meeting Expectations?
A Customer-Driven Discussion About How Elevating Acumen In The Business of Oncology Can Strengthen Customer Impact
![](https://www.magnoliainnovation.com/wp-content/uploads/C-Suite-Insights-1-pdf-791x1024.jpg.webp)
C-Suite Insights: Are Oncology Pharma Teams Meeting Expectations?
A Customer-Driven Discussion About How Elevating Acumen In The Business of Oncology Can Strengthen Customer Impact
![](https://www.magnoliainnovation.com/wp-content/uploads/C-Suite-Insights-2-pdf-791x1024.jpg.webp)
Stress, Inflammation, and Suboptimal Treatment Outcomes
psychoneuroimmunology deepens our understanding of the mind-body connection and biological pathways through which mental and physical health interact.
![](https://www.magnoliainnovation.com/wp-content/uploads/Psychoneuroimmunology-Article-FINAL-1-pdf-791x1024.jpg.webp)
Stress, Inflammation, and Suboptimal Treatment Outcomes
psychoneuroimmunology deepens our understanding of the mind-body connection and biological pathways through which mental and physical health interact.
![](https://www.magnoliainnovation.com/wp-content/uploads/Psychoneuroimmunology-Article-FINAL-2-pdf-791x1024.jpg.webp)
Researching, Recognizing, and Reaching the Rare
Our team of market researchers, data scientists and consultants built a patient finding strategy tailored to our client’s needs
![](https://www.magnoliainnovation.com/wp-content/uploads/MAG-9220-81qd-Case-Study-One-Pager_v09_FINAL2-5-pdf-791x1024.jpg.webp)
Researching, Recognizing, and Reaching the Rare
Our team of market researchers, data scientists and consultants built a patient finding strategy tailored to our client’s needs
![](https://www.magnoliainnovation.com/wp-content/uploads/MAG-9220-81qd-Case-Study-One-Pager_v09_FINAL2-6-pdf-791x1024.jpg.webp)
Many Vendors or One Partner?
Read how a small biopharma company relied on a single vendor to launch a market-leading drug.
![oncologist segmentation cover](https://www.magnoliainnovation.com/wp-content/uploads/Biohaven-Article-Thumbnail_Page_1.png.webp)
Many Vendors Or One Partner?
Read how a small biopharma company relied on a single vendor to launch a market-leading drug.
![oncologist segmentation cover](https://www.magnoliainnovation.com/wp-content/uploads/Biohaven-Article-Thumbnail_Page_1.png.webp)
COVID-19: Impact on the Rare Disease Community
Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic
![](https://www.magnoliainnovation.com/wp-content/uploads/COVID-19-Rare-Disease-Community-7-pdf-791x1024.jpg.webp)
COVID-19: Impact on the Rare Disease Community
Learn the ways pharma can empower rare disease patients during the uncertainty of the COVID-19 Pandemic
![](https://www.magnoliainnovation.com/wp-content/uploads/COVID-19-Rare-Disease-Community-8-pdf-791x1024.jpg.webp)
Oncologist Segmentation
Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists
![](https://www.magnoliainnovation.com/wp-content/uploads/Oncology-Segmentation-2-pdf-791x1024.jpg.webp)
Oncologist Segmentation
Learn how to tailor personal and non-personal promotion based on attitudinal differences among oncologists
![](https://www.magnoliainnovation.com/wp-content/uploads/Oncology-Segmentation-1-pdf-791x1024.jpg.webp)
Benchmarking the COVID-19 Pandemic
Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic
![](https://www.magnoliainnovation.com/wp-content/uploads/Benchmarking-Covid-1-pdf-791x1024.jpg.webp)
Benchmarking the COVID-19 Pandemic
Explore key lessons from other historical events to inform effective ways to manage the COVID-19 pandemic
![](https://www.magnoliainnovation.com/wp-content/uploads/Benchmarking-Covid-2-pdf-791x1024.jpg.webp)
The Hidden Burden
Optimize commercial efforts by understanding the common challenges in the rare disease landscape
![](https://www.magnoliainnovation.com/wp-content/uploads/The-Hidden-Burden-2-pdf-791x1024.jpg.webp)
The Hidden Burden
Optimize commercial efforts by understanding the common challenges in the rare disease landscape
![](https://www.magnoliainnovation.com/wp-content/uploads/The-Hidden-Burden-1-pdf-791x1024.jpg.webp)
Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)
Understand the Debilitating effects of ph1 to identify the opportunities for Easier diagnosis and effective therapies
![](https://www.magnoliainnovation.com/wp-content/uploads/Understanding-the-Burden-of-Primary-Hyperoxaluria-Type-1-PH1-2-pdf-709x1024.jpg.webp)
Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)
Understanding the Debilitating effects of Ph1 to identify the Opportunities for Easier diagnosis and effective therapies
![understanding the burden of primary hyperoxaluria type 1 (ph1)](https://www.magnoliainnovation.com/wp-content/uploads/Understanding-the-Burden-of-Primary-Hyperoxaluria-Type-1-PH1-709x1024.png.webp)